Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster

Journal of Clinical Investigation

Volumn 119, Issue 9, 2009, Pages 2634-2647

  Boettger, Thomas ^a   Beetz, Nadine ^b   Kostin, Sawa ^a   Schneider, Johanna ^b   Krüger, Marcus ^a   Hein, Lutz ^b   Braun, Thomas ^a  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CALDESMON; CALPONIN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; PHENYLEPHRINE; SMOOTHELIN; TPM4 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTERY MUSCLE; ARTICLE; CONTROLLED STUDY; GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENETIC MANIPULATION; ISOTOPE LABELING; MIR143 GENE; MIR145 GENE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PHENOTYPE; PHENOTYPIC MODULATION; PRIORITY JOURNAL; PROTEOMICS; REGULATORY MECHANISM; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARTERIES; BASE SEQUENCE; CAPTOPRIL; HUMANS; LOSARTAN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; MULTIGENE FAMILY; MUSCLE CONTRACTION; MYOCYTES, SMOOTH MUSCLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; TUNICA INTIMA;

EID: 70349213385     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38864     Document Type: Article

References (53)

1. Owens, G.K., Kumar, M.S., and Wamhoff, B.R. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:767-801. (Pubitemid 38823766)
2. Rensen, S.S., Doevendans, P.A., and van Eys, G.J. 2007. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 15:100-108. (Pubitemid 47253691)
3. Doran, A.C., Meller, N., and McNamara, C.A. 2008. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28:812-819. (Pubitemid 351544093)
4. Ross, R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791-804.
5. Bartel, D.P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281-297.
6. Landgraf, P., et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 129:1401-1414. (Pubitemid 46970709)
7. Zhao, Y., et al. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 129:303-317. (Pubitemid 46574975)
8. Makeyev, E.V., Zhang, J., Carrasco, M.A., and Maniatis, T. 2007. The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell. 27:435-448. (Pubitemid 47126944)
9. Leucht, C., et al. 2008. MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat. Neurosci. 11:641-648. (Pubitemid 351748112)
10. Ruzicka, D.L., and Schwartz, R.J. 1988. Sequential activation of alpha-actin genes during avian cardiogenesis: vascular smooth muscle alpha-actin gene transcripts mark the onset of cardiomyocyte differentiation. J. Cell Biol. 107:2575-2586.
11. Li, L., Miano, J.M., Cserjesi, P., and Olson, E.N. 1996. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ. Res. 78:188-195. (Pubitemid 26042837)
12. Rishniw, M., Xin, H.B., Deng, K.Y., and Kotlikoff, M.I. 2003. Skeletal myogenesis in the mouse esophagus does not occur through transdifferentiation. Genesis. 36:81-82. (Pubitemid 36818666)
13. Pfitzer, G., and Boels, P.J. 1991. Differential skinning of smooth muscle: a new approach to excitation-contraction coupling. Blood Vessels. 28:262-267.
14. Khromov, A.S., et al. 2006. Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation. Proc. Natl. Acad. Sci. U. S. A. 103:2440-2445.
15. Kruger, M., et al. 2008. SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell. 134:353-364. (Pubitemid 352010327)
16. John, B., et al. 2004. Human microRNA targets. PLoS Biol. 2:e363.
17. Betel, D., Wilson, M., Gabow, A., Marks, D.S., and Sander, C. 2008. The microRNA.org resource: targets and expression. Nucleic Acids Res. 36:D149-D153.
18. Griffiths-Jones, S., Saini, H.K., van Dongen, S., and Enright, A.J. 2008. miRBase: tools for microRNA genomics. Nucleic Acids Res. 36:D154-D158.
19. Grimson, A., et al. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell. 27:91-105. (Pubitemid 46991392)
20. Bussey, K.J., et al. 2003. MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biol. 4:R27.
21. Abouhamed, M., Reichenberg, S., Robenek, H., and Plenz, G. 2003. Tropomyosin 4 expression is enhanced in dedifferentiating smooth muscle cells in vitro and during atherogenesis. Eur. J. Cell Biol. 82:473-482. (Pubitemid 37266046)
22. Potapova, I.A., Cohen, I.S., and Doronin, S.V. 2007. Voltage-gated ion channel Kv4.3 is associated with Rap guanine nucleotide exchange factors and regulates angiotensin receptor type 1 signaling to small G-protein Rap. FEBS J. 274:4375-4384.
23. Miralles, F., Posern, G., Zaromytidou, A.I., and Treisman, R. 2003. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 113:329-342. (Pubitemid 36556115)
24. Ji, R., et al. 2007. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ. Res. 100:1579-1588. (Pubitemid 46897261)
25. Xu, Q. 2004. Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am. J. Pathol. 165:1-10. (Pubitemid 38821809)
26. Farh, K.K., et al. 2005. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science. 310:1817-1821.
27. Wang, D., et al. 2001. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 105:851-862. (Pubitemid 32635087)
28. Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J.A., and Kosik, K.S. 2009. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 137:647-658.
29. Dzau, V.J. 2001. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 37:1047-1052.
30. Touyz, R.M. 2005. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Exp. Physiol. 90:449-455.
31. Schieffer, B., et al. 2000. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 101:1372-1378. (Pubitemid 30169857)
32. Griendling, K.K., et al. 1987. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J. Biol. Chem. 262:14555-14562. (Pubitemid 17157360)
33. Lassegue, B., et al. 1995. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol. Pharmacol. 48:601-609.
34. Wang, X., et al. 2008. RGS5, RGS4, and RGS2 expression and aortic contractibility are dynamically co-regulated during aortic banding-induced hypertrophy. J. Mol. Cell. Cardiol. 44:539-550.
35. Hercule, H.C., et al. 2007. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice. Exp. Physiol. 92:1014-1022. (Pubitemid 47568838)
36. Lyssand, J.S., et al. 2008. Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome. J. Biol. Chem. 283:18792-18800.
37. Krege, J.H., et al. 1997. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension. 29:150-157. (Pubitemid 27074036)
38. Seitz, H. 2009. Redefining microRNA targets. Curr. Biol. 19:870-873.
39. Penn, B.H., Bergstrom, D.A., Dilworth, F.J., Bengal, E., and Tapscott, S.J. 2004. A MyoD-generated feedforward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes Dev. 18:2348-2353. (Pubitemid 39304681)
40. Stary, H.C., et al. 1994. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 89:2462-2478. (Pubitemid 24142837)
41. Ip, J.H., et al. 1990. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J. Am. Coll. Cardiol. 15:1667-1687.
42. Ross, R., and Glomset, J.A. 1973. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 180:1332-1339.
43. Daugherty, A., Manning, M.W., and Cassis, L.A. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105:1605-1612. (Pubitemid 30390311)
44. Halkin, A., and Keren, G. 2002. Potential indications for angiotensin-converting enzyme inhibitors in atherosclerotic vascular disease. Am. J. Med. 112:126-134. (Pubitemid 34142544)
45. Warming, S., Costantino, N., Court, D.L., Jenkins, N.A., and Copeland, N.G. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36. (Pubitemid 41439937)
46. Voss, A.K., Thomas, T., and Gruss, P. 1997. Germ line chimeras from female ES cells. Exp. Cell Res. 230:45-49. (Pubitemid 27187538)
47. Scholz, D., et al. 2000. Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch. 436:257-270. (Pubitemid 30168685)
48. Cox, J., and Mann, M. 2007. Is proteomics the new genomics? Cell. 130:395-398. (Pubitemid 47198310)
49. Graumann, J., et al. 2008. Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol. Cell. Proteomics. 7:672-683. (Pubitemid 351597479)
50. Kersey, P.J., et al. 2004. The International Protein Index: an integrated database for proteomics experiments. Proteomics. 4:1985-1988.
51. Brede, M., et al. 2002. Feedback inhibition of catecholamine release by two different alpha2-adrenoceptor subtypes prevents progression of heart failure. Circulation. 106:2491-2496. (Pubitemid 35278807)
52. Brede, M., et al. 2001. Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor. Circulation. 104:2602-2607. (Pubitemid 33104800)
53. Fabiato, A., and Fabiato, F. 1979. Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J. Physiol. (Paris). 75:463-505. (Pubitemid 10241310)